603501:SSEOmniVision Integrated Circuits Group, Inc. Class A Analysis
Data as of 2026-07-26 - not real-time
CN¥96.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
OmniVision is trading below its 20‑day (≈101) and 50‑day (≈98) moving averages, with an RSI hovering in the mid‑40s and a MACD histogram firmly in negative territory, indicating short‑term bearish momentum.
Despite the technical weakness, the company’s fundamentals remain solid: a trailing P/E close to the industry average, a forward P/E that is materially lower, healthy cash reserves that exceed total debt, a modest payout ratio and a dividend yield near 0.7%, and ROE above 12%. The high 30‑day volatility (≈52%) contrasts with a low beta, suggesting price swings are more company‑specific than market‑driven, while the “Extreme Greed” sentiment reflects strong market appetite for tech stocks.
Despite the technical weakness, the company’s fundamentals remain solid: a trailing P/E close to the industry average, a forward P/E that is materially lower, healthy cash reserves that exceed total debt, a modest payout ratio and a dividend yield near 0.7%, and ROE above 12%. The high 30‑day volatility (≈52%) contrasts with a low beta, suggesting price swings are more company‑specific than market‑driven, while the “Extreme Greed” sentiment reflects strong market appetite for tech stocks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price below short‑term moving averages
- bearish MACD signal
- stable trading volume supporting liquidity
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward earnings estimate indicating earnings growth
- lower forward P/E relative to trailing P/E and industry
- strong cash position and low debt improving financial flexibility
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- diversified product portfolio across automotive, medical and AI imaging
- moderate dividend yield with low payout ratio supporting sustainability
- sector cyclicality and regulatory environment in China adding uncertainty
Key Metrics & Analysis
Financial Health
Revenue Growth-0.90%
Profit Margin12.79%
P/E Ratio31.9
ROE12.58%
ROA5.93%
Debt/Equity30.50
P/B Ratio3.7
Op. Cash FlowCN¥3.8B
Free Cash FlowCN¥366.0M
Industry P/E32.9
Technical Analysis
TrendNeutral
RSI46.1
SupportCN¥84.63
ResistanceCN¥113.77
MA 20CN¥101.22
MA 50CN¥97.64
MA 200CN¥113.24
MACDBearish
VolumeStable
Fear & Greed Index88.25
Valuation
Fair ValueCN¥9.11
GradeFair
TypeBlend
Dividend Yield0.74%
Risk Assessment
Beta0.31
Volatility51.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.